Precigen (NasdaqGS:PGEN) Q4 2025 Earnings call March 25, 2026 04:30 PM ET Speaker5This call is being recorded on Wednesday, March 25, 2026. I would now like to turn the conference over to Steven Harasym. Please go ahead.Speaker8Thank you, operator, and thank you to all those joining us for our fourth quarter and year-end 2025 update call. Joining me today are Helen Sabzevari, our President and CEO, Phil Tennant, our Chief Commercial Officer, and Harry Thomasian Jr., our CFO. Before we begin our prepared rem ...

Tivic Health Systems (NasdaqCM:TIVC) Q4 2025 Earnings call March 25, 2026 04:30 PM ET Speaker2Welcome to Tivic's conference call to discuss fiscal year and fourth quarter 2025 financial results. This call has been pre-recorded. This call is being webcast, and the replay will be available on the IR section of the company's website for three months. Before we begin, please note that during today's call, management will make various forward-looking statements. Investors are cautioned that these forward-looking ...

GCT Semiconductor (NYSE:GCTS) Q4 2025 Earnings call March 25, 2026 04:30 PM ET Speaker4Good afternoon. Thank you for attending GCT Semiconductor Holding, Inc.'s fourth quarter and full year 2025 financial results call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. Joining the call today are John Schlaefer, GCT's Chief Executive Officer, and Edmond Cheng, CFO, to discuss our fourth quarter and full year 2025 results. During this ...

Celcuity (NasdaqCM:CELC) Q4 2025 Earnings call March 25, 2026 04:30 PM ET Speaker10I would now like to turn the conference over to Jodi Severs, Corporate Communications and Investor Relations at Celcuity. Please go ahead.Speaker5Thank you, John, and good afternoon, everyone. Thank you for joining us to review Celcuity's fourth quarter and full year 2025 financial results and business update. Earlier today, Celcuity Inc. released financial results for the fourth quarter and full year ended December 31, 2025. ...

Cardiff Oncology (NasdaqCM:CRDF) Update / briefing March 25, 2026 04:30 PM ET Company ParticipantsHeinz-Josef Lenz - University Professor of Medicine, Preventive Medicine, and Cancer BiologyMani Mohindru - Interim CEOScott Kopetz - Professor and Deputy Chair in the Department of Gastrointestinal Medical OncologyConference Call ParticipantsMarc Frahm - Managing Director and Senior Research AnalystMaury Raycroft - Equity Research AnalystModeratorPlease be advised that today's conference is being recorded. I w ...

Journey Medical (NasdaqCM:DERM) Q4 2025 Earnings call March 25, 2026 04:30 PM ET Speaker5Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's Full Year 2025 Financial Results and Corporate Update conference call. At this time, all participants are in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. Participants of this call are advised that the audio of this conference call is being bro ...

Ryvyl (NasdaqCM:RVYL) 2026 Extraordinary General Meeting March 25, 2026 04:00 PM ET Company ParticipantsGeorge Oliva - Interim CEO, CFO, and DirectorGeorge OlivaGood afternoon, and welcome to the postponed special meeting of stockholders of Ryvyl Inc. Thank you all for joining us today. I am George Oliva, Interim CEO and CFO, and a Director of Ryvyl Inc. I'll be serving as the Chair of today's special meeting of stockholders. Jasmine Farrington will serve as Secretary of the meeting. We are pleased to again ...

Investor Presentation Third Quarter FY26 NASDAQ: MLKN Forward looking statements or operating results. or financial condition or the price of our stock. import. – Global and national economic conditions such as heightened inflation, uncertainty regarding future interest rates, foreign currency exchange rate fluctuations, the escalating conflict in the Middle East, the continuation of the Russia-Ukraine war, and potential governmental responses to these events; – Cybersecurity threats and risks; – Public hea ...

An AI-Powered Marketplace Platform Helping SMBs Access Better Self-Funded Health Plans Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT," "we," "our," or "us") solely for informational purposes. The information included herein in this presentation has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers or representatives as ...

Investor Presentation Q4 Fiscal 2026 Safe Harbor Disclaimer This presentation contains "forward-looking statementsˮ within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Navan's anticipated total revenue, non-GAAP income (loss) from operations, and non-GAAP operating margin for the fiscal quarter ending April 30, 2026 and fiscal year ending January 31, 2027, the size of Navan's market opportunity, market trends, and the company's busi ...